You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 9, September 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Radiologic Imaging
 •Immunologic Disorders
 •Cognitive Disorders
 •Multiple Sclerosis/ Demyelinating Disease
 •Magnetic Resonance Imaging
 •Alert me on articles by topic

Neocortical Atrophy, Third Ventricular Width, and Cognitive Dysfunction in Multiple Sclerosis

Ralph H. B. Benedict, PhD; Jared M. Bruce, PhD; Michael G. Dwyer, BS; Nadir Abdelrahman, MD; Sarah Hussein, BS; Bianca Weinstock-Guttman, MD; Neeta Garg, MD; Frederick Munschauer, MD; Robert Zivadinov, MD

Arch Neurol. 2006;63:1301-1306.

Background  Cognitive dysfunction is common in multiple sclerosis (MS). Correlations are reported between atrophy and neuropsychological test results.

Objective  To determine if neocortical volume would supplant or supplement third ventricular width and other magnetic resonance imaging measures when predicting neuropsychological impairment.

Design  Cross-sectional study.

Setting  University MS clinic.

Participants  Seventy-seven patients with relapsing-remitting MS, 42 patients with secondary progressive MS, and 27 healthy control subjects.

Main Outcome Measures  Brain atrophy and lesion burden measures were obtained in all patients. A subset of 82 patients and all controls underwent neuropsychological testing.

Results  Patients with secondary progressive MS had more atrophy than patients with relapsing-remitting MS and controls. Neocortical volume was significantly correlated with all neuropsychological measures, with r values ranging from 0.29 to 0.58. Third ventricular width was retained in most stepwise regression analyses predicting cognitive impairment in patients with MS and distinguishing secondary progressive from relapsing-remitting courses of MS.

Conclusions  We confirm an association between neocortical volume and multiple cognitive domains in MS, although neocortical volume did not explain significantly more variance than other magnetic resonance imaging measures. Of the magnetic resonance imaging variables studied, third ventricular width was retained in most regression models.


Author Affiliations: Department of Neurology, School of Medicine, State University of New York at Buffalo, and Jacobs Neurological Institute (Drs Benedict and Zivadinov) and Buffalo Neuroimaging Analysis Center (Drs Benedict, Bruce, Abdelrahman, Weinstock-Guttman, Garg, Munschauer, and Zivadinov, Mr Dwyer, and Ms Hussein).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study
Horakova et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:407-414.
ABSTRACT | FULL TEXT  

Regional hippocampal atrophy in multiple sclerosis
Sicotte et al.
Brain 2008;131:1134-1141.
ABSTRACT | FULL TEXT  

Cognitive impairment in relapsing--remitting multiple sclerosis can be predicted by imaging performed several years earlier
Summers et al.
Mult Scler 2008;14:197-204.
ABSTRACT  

Comparison of Three Different Methods for Measurement of Cervical Cord Atrophy in Multiple Sclerosis
Zivadinov et al.
Am. J. Neuroradiol. 2008;29:319-325.
ABSTRACT | FULL TEXT  

Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis
Amato et al.
Arch Neurol 2007;64:1157-1161.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.